Personalis, Inc(NASDAQ:PSNL) 
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and dia...
Website: http://www.personalis.com
Founded: 2011
IPO Price: $17 (Jun 20, 2019)
Full Time Employees: 181
CEO: John S. West
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.11
H 3.21
L 2.93
C 3.11
V 924,780
10EMA 3.11
20EMA 3.11
60EMA 3.11
120EMA 3.11
250EMA 3.11